The SeniorCare Investor: Skilled Nursing At An Impasse?

Seniorcare

  Always Nervous About Medicare, SNFs Deal With Reform At least once a decade, the skilled nursing sector seems to be under attack, although we are sure there are providers who think it is every year. Either for quality of care issues or reimbursement, politicians and...

EXPERT OPINION: A Conversation with Steve Gilleland

Seniorcare

In this “Expert Opinion” interview, Steve Gilleland discusses the state of the lending market and some of CapitalSource’s loan programs, what types of borrowers are looking for capital and how he sees his loan volume in the next year or two. Listen Now    ...

EXPERT OPINION: A Conversation with Larry Cohen

Seniorcare

Larry Cohen, Vice Chairman of the Board and CEO, Capital Senior Living In this “Expert Opinion” interview, Larry Cohen discusses some of the current trends in the seniors housing industry and how Capital Senior Living has adjusted its model and expanded...

The Health Care M&A Monthly: Abbott Snags Solvay Pharma–

Healthcare

  Pays $7.6 Billion To Enter Vaccines, Emerging Markets After several months of intense speculation, the rumors surrounding Solvay Pharmaceuticals’ fate may be put to rest at last. Parent Solvay AG (NYSE-Euronext Brussels: SOLB.BE) has finally found a buyer in Abbott...